- Home
- ITOS vs NAMI Comparison
ITOS vs NAMI Comparison
Compare ITOS & NAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- NAMI
- Stock Information
- Founded
- ITOS 2011
- NAMI 2014
- Country
- ITOS United States
- NAMI China
- Employees
- ITOS N/A
- NAMI N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- NAMI
- Sector
- ITOS Health Care
- NAMI
- Exchange
- ITOS Nasdaq
- NAMI NYSE
- Market Cap
- ITOS 271.1M
- NAMI 286.0M
- IPO Year
- ITOS 2020
- NAMI 2024
- Fundamental
- Price
- ITOS $7.41
- NAMI $4.38
- Analyst Decision
- ITOS Strong Buy
- NAMI
- Analyst Count
- ITOS 3
- NAMI 0
- Target Price
- ITOS $21.33
- NAMI N/A
- AVG Volume (30 Days)
- ITOS 512.7K
- NAMI 352.7K
- Earning Date
- ITOS 11-12-2024
- NAMI 02-11-2025
- Dividend Yield
- ITOS N/A
- NAMI N/A
- EPS Growth
- ITOS N/A
- NAMI N/A
- EPS
- ITOS N/A
- NAMI 0.37
- Revenue
- ITOS $35,000,000.00
- NAMI $56,127,097.00
- Revenue This Year
- ITOS $271.18
- NAMI N/A
- Revenue Next Year
- ITOS N/A
- NAMI N/A
- P/E Ratio
- ITOS N/A
- NAMI $11.76
- Revenue Growth
- ITOS N/A
- NAMI 64.40
- 52 Week Low
- ITOS $7.09
- NAMI $3.75
- 52 Week High
- ITOS $18.75
- NAMI $7.75
- Technical
- Relative Strength Index (RSI)
- ITOS 36.39
- NAMI N/A
- Support Level
- ITOS $7.09
- NAMI N/A
- Resistance Level
- ITOS $7.53
- NAMI N/A
- Average True Range (ATR)
- ITOS 0.37
- NAMI 0.00
- MACD
- ITOS -0.02
- NAMI 0.00
- Stochastic Oscillator
- ITOS 21.28
- NAMI 0.00
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About NAMI JINXIN TECHNOLOGY HOLDING COMPANY SPONSORED ADS EACH REP 18 ORD SHS
Jinxin Technology Holding Co is a company which operates through its subsidiaries are principally engaged in provision of digital textbook subscription services in the People's Republic of China. The Company generates revenue by selling its content to hardware manufacturers in China whereby they are allowed to install the Company's digital educational content on the manufacturers' devices for sale to end users.